Comparison of the long-term risk of recurrence and other clinical outcomes in GIST patients receiving imatinib as adjuvant therapy--a retrospective chart extract-based approach
J Gastrointest Cancer. 2013 Jun;44(2):190-8
View abstract
Authors
Conley AP,
Guerin A, Sasane M, Gauthier G, Schwiep F, Keir CH,
Wu EQ